Eyenuk

Woodland Hills, United States

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.

$26.0M raised

Oct 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eyenuk raised?

Eyenuk has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.

Who are Eyenuk's investors?

Eyenuk's investors include AXA Investment Managers, KOFA Healthcare, Kendall Capital Partners, Global Health Investment Fund (GHIF), T&W Medical.

Where is Eyenuk headquartered?

Eyenuk is headquartered in Woodland Hills, United States.

What does Eyenuk do?

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.

What stage is Eyenuk at?

Eyenuk is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 17, 2022.

MLA

"Eyenuk — Funding & Investors." VCBacked, October 17, 2022, https://www.vcbacked.co/company/eyenuk. Accessed July 2, 2026.

APA

VCBacked. (2022). Eyenuk — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/eyenuk

Wikipedia (cite web)

{{cite web |title=Eyenuk — Funding & Investors |url=https://www.vcbacked.co/company/eyenuk |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 17, 2022.